We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1976
TriMas Corp
TRS
$1.44B
| $1.7M | ﹤0.01% |
67,174
+320
| +0.5% | +$7.91K |
|
1977
Corsair Gaming
CRSR
$1.55B
| $1.7M | ﹤0.01% |
120,316
+2,912
| +2% | +$39K |
|
|
UDMY
1978
DELISTED
Udemy
UDMY
| $1.7M | ﹤0.01% |
115,132
+2,088
| +2% | +$26K |
|
1979
iShares Russell Mid-Cap ETF
IWR
$57.5B
| $1.69M | ﹤0.01% |
21,800
-1,139
| -5% | -$80.9K |
|
|
NFBK
1980
DELISTED
Northfield Bancorp
NFBK
| $1.69M | ﹤0.01% |
134,635
+2,284
| +2% | +$23K |
|
1981
Mesa Laboratories
MLAB
$574M
| $1.69M | ﹤0.01% |
16,156
+571
| +4% | +$55.6K |
|
|
ATSG
1982
DELISTED
Air Transport Services Group
ATSG
| $1.69M | ﹤0.01% |
96,011
+1,895
| +2% | +$33.7K |
|
|
RYZB
1983
DELISTED
RayzeBio, Inc. Common Stock
RYZB
| $1.69M | ﹤0.01% |
+27,158
| New | +$675K |
|
1984
Scholar Rock
SRRK
$6.44B
| $1.69M | ﹤0.01% |
89,750
+26,162
| +41% | +$325K |
|
1985
Ennis
EBF
$564M
| $1.68M | ﹤0.01% |
76,790
-722
| -0.9% | -$15.6K |
|
1986
iShares MSCI Sweden ETF
EWD
$595M
| $1.68M | ﹤0.01% |
42,600
-6,650
| -14% | -$233K |
|
1987
AstraZeneca
AZN
$250B
| $1.68M | ﹤0.01% |
12,483
+308
| +3% | +$40K |
|
1988
Sprinklr
CXM
$1.61B
| $1.68M | ﹤0.01% |
139,623
+1,284
| +0.9% | +$17.6K |
|
1989
Malibu Boats
MBUU
$567M
| $1.68M | ﹤0.01% |
30,587
-70
| -0.2% | -$3.36K |
|
|
EHAB
1990
DELISTED
Enhabit
EHAB
| $1.67M | ﹤0.01% |
161,809
-1,036
| -0.6% | -$9.79K |
|
1991
Coeur Mining
CDE
$17.9B
| $1.67M | ﹤0.01% |
512,705
+8,531
| +2% | +$23.3K |
|
1992
Reynolds Consumer Products
REYN
$5.59B
| $1.67M | ﹤0.01% |
62,125
+1,600
| +3% | +$41.8K |
|
1993
Relay Therapeutics
RLAY
$4.33B
| $1.67M | ﹤0.01% |
151,445
-1,732
| -1% | -$14.6K |
|
1994
Energy Recovery
ERII
$443M
| $1.66M | ﹤0.01% |
88,111
-5,640
| -6% | -$105K |
|
1995
KE Holdings
BEKE
$18.8B
| $1.65M | ﹤0.01% |
102,069
+1,328
| +1% | +$20.5K |
|
1996
AvePoint
AVPT
$2.71B
| $1.65M | ﹤0.01% |
201,085
-1,755
| -0.9% | -$13.7K |
|
|
AKRO
1997
DELISTED
Akero Therapeutics
AKRO
| $1.65M | ﹤0.01% |
70,699
-85
| -0.1% | -$1.68K |
|
|
SAGE
1998
DELISTED
Sage Therapeutics
SAGE
| $1.64M | ﹤0.01% |
75,683
-361
| -0.5% | -$7.15K |
|
1999
MiMedx Group
MDXG
$633M
| $1.64M | ﹤0.01% |
186,619
+816
| +0.4% | +$5.97K |
|
2000
Aurinia Pharmaceuticals
AUPH
$2.11B
| $1.63M | ﹤0.01% |
181,344
+664
| +0.4% | +$5.47K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.